Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure

Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction

(2010) Jasper W.L. Hartog et al.   EUROPEAN JOURNAL OF HEART FAILURE

Tumor necrosis factor-α produced in cardiomyocytes mediates a predominant myocardial inflammatory response to stretch in early volume overload

(2010) Yuanwen Chen et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes

(2009) Lin Lu et al.   ATHEROSCLEROSIS

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

(2009) Stephane Heymans et al.   EUROPEAN JOURNAL OF HEART FAILURE

RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation

(2009) Louis J Sparvero et al.   Journal of Translational Medicine

Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients

(2008) Xiao Xiang Yan et al.   ATHEROSCLEROSIS

High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice

(2008) T. Kitahara et al.   CARDIOVASCULAR RESEARCH

Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling

(2008) T. Kohno et al.   CARDIOVASCULAR RESEARCH

High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart

(2008) Martin Andrassy et al.   CIRCULATION

Modulated Inflammation by Injection of High-Mobility Group Box 1 Recovers Post-Infarction Chronically Failing Heart

(2008) K. Takahashi et al.   CIRCULATION

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

(2008) Angela Raucci et al.   FASEB JOURNAL

Soluble Receptor for Advanced Glycation End Products (RAGE) is a Prognostic Factor for Heart Failure

(2008) Yo Koyama et al.   JOURNAL OF CARDIAC FAILURE

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications

(2007) Giuseppina Basta   ATHEROSCLEROSIS